PDB Short entry for 2VQ5 HEADER LYASE 11-MAR-08 2VQ5 TITLE X-RAY STRUCTURE OF NORCOCLAURINE SYNTHASE FROM THALICTRUM FLAVUM IN TITLE 2 COMPLEX WITH DOPAMINE AND HYDROXYBENZALDEHYDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: S-NORCOCLAURINE SYNTHASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RESIDUES 16-210; COMPND 5 SYNONYM: NORCOCLAURINE SYNTHASE FROM THALICTRUM FLAVUM; COMPND 6 EC: 4.2.1.78; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES; COMPND 9 OTHER_DETAILS: THE PROTEIN LACKS THE FIRST 15 RESIDUES AND IS HIS- COMPND 10 TAGGED AT THE C-TERMINUS. SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: THALICTRUM FLAVUM; SOURCE 3 ORGANISM_TAXID: 150094; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 6 EXPRESSION_SYSTEM_STRAIN: BL21DE3; SOURCE 7 EXPRESSION_SYSTEM_PLASMID: PET22-B KEYWDS LYASE, NORCOCLAURINE SYNTHASE, S- NORCOCLAURINE BIOSYNTHESIS, KEYWDS 2 DOPAMINE, HYDROXYBENZALDEHYDE EXPDTA X-RAY DIFFRACTION AUTHOR A.ILARI,S.FRANCESCHINI,A.BONAMORE,A.BOFFI REVDAT 4 13-DEC-23 2VQ5 1 LINK REVDAT 3 13-JAN-09 2VQ5 1 VERSN JRNL REVDAT 2 25-NOV-08 2VQ5 1 JRNL REMARK REVDAT 1 05-AUG-08 2VQ5 0 JRNL AUTH A.ILARI,S.FRANCESCHINI,A.BONAMORE,F.ARENGHI,B.BOTTA, JRNL AUTH 2 A.MACONE,A.PASQUO,L.BELLUCCI,A.BOFFI JRNL TITL STRUCTURAL BASIS OF ENZYMATIC S-NORCOCLAURINE BIOSYNTHESIS. JRNL REF J.BIOL.CHEM. V. 284 897 2009 JRNL REFN ISSN 0021-9258 JRNL PMID 19004827 JRNL DOI 10.1074/JBC.M803738200 REMARK 2 REMARK 2 RESOLUTION. 2.09 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.09 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 97.7 REMARK 3 NUMBER OF REFLECTIONS : 28573 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.223 REMARK 3 R VALUE (WORKING SET) : 0.221 REMARK 3 FREE R VALUE : 0.266 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1508 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.09 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.14 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2045 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2650 REMARK 3 BIN FREE R VALUE SET COUNT : 99 REMARK 3 BIN FREE R VALUE : 0.3560 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2556 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 42 REMARK 3 SOLVENT ATOMS : 173 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.38 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.01000 REMARK 3 B22 (A**2) : -0.01000 REMARK 3 B33 (A**2) : 0.02000 REMARK 3 B12 (A**2) : -0.01000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.190 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.179 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.136 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 5.069 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.941 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.921 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2691 ; 0.010 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3654 ; 1.288 ; 1.989 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 333 ;10.238 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 99 ;36.639 ;25.152 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 468 ;16.793 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 3 ;19.218 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 421 ; 0.087 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1970 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1232 ; 0.209 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1766 ; 0.304 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 165 ; 0.150 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 59 ; 0.238 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 14 ; 0.166 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1720 ; 0.816 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2695 ; 1.304 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1130 ; 1.840 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 957 ; 2.754 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 2VQ5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 11-MAR-08. REMARK 100 THE DEPOSITION ID IS D_1290035458. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.972 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 30118 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.8 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 13.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.18 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.3 REMARK 200 DATA REDUNDANCY IN SHELL : 3.10 REMARK 200 R MERGE FOR SHELL (I) : 0.51000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 2VNE REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 61.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.20 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: AMMONIUM SULFATE 1.4-1.8 M, NACL 0.2 REMARK 280 M, ACETATE BUFFER PH 4.0-4.5, PH 4.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 39.32567 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 78.65133 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 78.65133 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 39.32567 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 TOTAL BURIED SURFACE AREA: 12410 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 38240 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -39.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 -39.32567 REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED RESIDUE IN CHAIN A, THR 16 TO MSE REMARK 400 ENGINEERED RESIDUE IN CHAIN A, ILE 17 TO THR REMARK 400 ENGINEERED RESIDUE IN CHAIN A, ASN 18 TO GLY REMARK 400 ENGINEERED RESIDUE IN CHAIN A, CYS 19 TO SER REMARK 400 ENGINEERED RESIDUE IN CHAIN B, THR 16 TO MSE REMARK 400 ENGINEERED RESIDUE IN CHAIN B, ILE 17 TO THR REMARK 400 ENGINEERED RESIDUE IN CHAIN B, ASN 18 TO GLY REMARK 400 ENGINEERED RESIDUE IN CHAIN B, CYS 19 TO SER REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MSE A 16 REMARK 465 THR A 17 REMARK 465 GLY A 18 REMARK 465 PRO A 28 REMARK 465 PHE A 29 REMARK 465 LEU A 30 REMARK 465 HIS A 31 REMARK 465 HIS A 32 REMARK 465 GLN A 33 REMARK 465 SER A 198 REMARK 465 ASN A 199 REMARK 465 SER A 200 REMARK 465 ASP A 201 REMARK 465 GLU A 202 REMARK 465 ILE A 203 REMARK 465 GLU A 204 REMARK 465 ALA A 205 REMARK 465 ALA A 206 REMARK 465 ILE A 207 REMARK 465 ILE A 208 REMARK 465 THR A 209 REMARK 465 VAL A 210 REMARK 465 HIS A 211 REMARK 465 HIS A 212 REMARK 465 HIS A 213 REMARK 465 HIS A 214 REMARK 465 HIS A 215 REMARK 465 HIS A 216 REMARK 465 MSE B 16 REMARK 465 THR B 17 REMARK 465 GLY B 18 REMARK 465 SER B 19 REMARK 465 GLN B 20 REMARK 465 LYS B 21 REMARK 465 LEU B 22 REMARK 465 ILE B 23 REMARK 465 LEU B 24 REMARK 465 THR B 25 REMARK 465 GLY B 26 REMARK 465 ARG B 27 REMARK 465 PRO B 28 REMARK 465 PHE B 29 REMARK 465 LEU B 30 REMARK 465 HIS B 31 REMARK 465 HIS B 32 REMARK 465 GLN B 33 REMARK 465 GLY B 34 REMARK 465 ILE B 35 REMARK 465 ILE B 36 REMARK 465 ASN B 37 REMARK 465 GLN B 38 REMARK 465 VAL B 39 REMARK 465 LYS B 195 REMARK 465 SER B 196 REMARK 465 LYS B 197 REMARK 465 SER B 198 REMARK 465 ASN B 199 REMARK 465 SER B 200 REMARK 465 ASP B 201 REMARK 465 GLU B 202 REMARK 465 ILE B 203 REMARK 465 GLU B 204 REMARK 465 ALA B 205 REMARK 465 ALA B 206 REMARK 465 ILE B 207 REMARK 465 ILE B 208 REMARK 465 THR B 209 REMARK 465 VAL B 210 REMARK 465 HIS B 211 REMARK 465 HIS B 212 REMARK 465 HIS B 213 REMARK 465 HIS B 214 REMARK 465 HIS B 215 REMARK 465 HIS B 216 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 105 123.09 -0.11 REMARK 500 GLU A 193 73.24 -67.76 REMARK 500 HIS A 194 90.83 -46.21 REMARK 500 ALA B 53 47.60 -81.52 REMARK 500 PRO B 105 131.38 -9.82 REMARK 500 THR B 148 -65.53 -99.71 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 PHE A 104 PRO A 105 -75.37 REMARK 500 PHE B 104 PRO B 105 -64.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 PHE B 104 -10.29 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A1198 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A1199 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A1200 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A1201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A1202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B1195 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B1196 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LDP B1197 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HBA A1203 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HBA B1198 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2VNE RELATED DB: PDB REMARK 900 THE X-RAY STRUCTURE OF NORCOCLAURINE SYNTHASE FROM THALICTRUM FLAVUM REMARK 999 REMARK 999 SEQUENCE REMARK 999 DATABASE NAME NCBI THE PROTEIN HAS SIX HIS AT THE C- REMARK 999 TERMINUS AND LACKS THE FIRST 15 RESIDUES DBREF 2VQ5 A 16 210 UNP Q67A25 Q67A25_9MAGN 16 210 DBREF 2VQ5 A 211 216 PDB 2VQ5 2VQ5 211 216 DBREF 2VQ5 B 16 210 UNP Q67A25 Q67A25_9MAGN 16 210 DBREF 2VQ5 B 211 216 PDB 2VQ5 2VQ5 211 216 SEQADV 2VQ5 MSE A 16 UNP Q67A25 THR 16 ENGINEERED MUTATION SEQADV 2VQ5 THR A 17 UNP Q67A25 ILE 17 ENGINEERED MUTATION SEQADV 2VQ5 GLY A 18 UNP Q67A25 ASN 18 ENGINEERED MUTATION SEQADV 2VQ5 SER A 19 UNP Q67A25 CYS 19 ENGINEERED MUTATION SEQADV 2VQ5 MSE B 16 UNP Q67A25 THR 16 ENGINEERED MUTATION SEQADV 2VQ5 THR B 17 UNP Q67A25 ILE 17 ENGINEERED MUTATION SEQADV 2VQ5 GLY B 18 UNP Q67A25 ASN 18 ENGINEERED MUTATION SEQADV 2VQ5 SER B 19 UNP Q67A25 CYS 19 ENGINEERED MUTATION SEQRES 1 A 201 MSE THR GLY SER GLN LYS LEU ILE LEU THR GLY ARG PRO SEQRES 2 A 201 PHE LEU HIS HIS GLN GLY ILE ILE ASN GLN VAL SER THR SEQRES 3 A 201 VAL THR LYS VAL ILE HIS HIS GLU LEU GLU VAL ALA ALA SEQRES 4 A 201 SER ALA ASP ASP ILE TRP THR VAL TYR SER TRP PRO GLY SEQRES 5 A 201 LEU ALA LYS HIS LEU PRO ASP LEU LEU PRO GLY ALA PHE SEQRES 6 A 201 GLU LYS LEU GLU ILE ILE GLY ASP GLY GLY VAL GLY THR SEQRES 7 A 201 ILE LEU ASP MSE THR PHE VAL PRO GLY GLU PHE PRO HIS SEQRES 8 A 201 GLU TYR LYS GLU LYS PHE ILE LEU VAL ASP ASN GLU HIS SEQRES 9 A 201 ARG LEU LYS LYS VAL GLN MSE ILE GLU GLY GLY TYR LEU SEQRES 10 A 201 ASP LEU GLY VAL THR TYR TYR MSE ASP THR ILE HIS VAL SEQRES 11 A 201 VAL PRO THR GLY LYS ASP SER CYS VAL ILE LYS SER SER SEQRES 12 A 201 THR GLU TYR HIS VAL LYS PRO GLU PHE VAL LYS ILE VAL SEQRES 13 A 201 GLU PRO LEU ILE THR THR GLY PRO LEU ALA ALA MSE ALA SEQRES 14 A 201 ASP ALA ILE SER LYS LEU VAL LEU GLU HIS LYS SER LYS SEQRES 15 A 201 SER ASN SER ASP GLU ILE GLU ALA ALA ILE ILE THR VAL SEQRES 16 A 201 HIS HIS HIS HIS HIS HIS SEQRES 1 B 201 MSE THR GLY SER GLN LYS LEU ILE LEU THR GLY ARG PRO SEQRES 2 B 201 PHE LEU HIS HIS GLN GLY ILE ILE ASN GLN VAL SER THR SEQRES 3 B 201 VAL THR LYS VAL ILE HIS HIS GLU LEU GLU VAL ALA ALA SEQRES 4 B 201 SER ALA ASP ASP ILE TRP THR VAL TYR SER TRP PRO GLY SEQRES 5 B 201 LEU ALA LYS HIS LEU PRO ASP LEU LEU PRO GLY ALA PHE SEQRES 6 B 201 GLU LYS LEU GLU ILE ILE GLY ASP GLY GLY VAL GLY THR SEQRES 7 B 201 ILE LEU ASP MSE THR PHE VAL PRO GLY GLU PHE PRO HIS SEQRES 8 B 201 GLU TYR LYS GLU LYS PHE ILE LEU VAL ASP ASN GLU HIS SEQRES 9 B 201 ARG LEU LYS LYS VAL GLN MSE ILE GLU GLY GLY TYR LEU SEQRES 10 B 201 ASP LEU GLY VAL THR TYR TYR MSE ASP THR ILE HIS VAL SEQRES 11 B 201 VAL PRO THR GLY LYS ASP SER CYS VAL ILE LYS SER SER SEQRES 12 B 201 THR GLU TYR HIS VAL LYS PRO GLU PHE VAL LYS ILE VAL SEQRES 13 B 201 GLU PRO LEU ILE THR THR GLY PRO LEU ALA ALA MSE ALA SEQRES 14 B 201 ASP ALA ILE SER LYS LEU VAL LEU GLU HIS LYS SER LYS SEQRES 15 B 201 SER ASN SER ASP GLU ILE GLU ALA ALA ILE ILE THR VAL SEQRES 16 B 201 HIS HIS HIS HIS HIS HIS MODRES 2VQ5 MSE A 97 MET SELENOMETHIONINE MODRES 2VQ5 MSE A 126 MET SELENOMETHIONINE MODRES 2VQ5 MSE A 140 MET SELENOMETHIONINE MODRES 2VQ5 MSE A 183 MET SELENOMETHIONINE MODRES 2VQ5 MSE B 97 MET SELENOMETHIONINE MODRES 2VQ5 MSE B 126 MET SELENOMETHIONINE MODRES 2VQ5 MSE B 140 MET SELENOMETHIONINE MODRES 2VQ5 MSE B 183 MET SELENOMETHIONINE HET MSE A 97 8 HET MSE A 126 13 HET MSE A 140 8 HET MSE A 183 13 HET MSE B 97 16 HET MSE B 126 8 HET MSE B 140 8 HET MSE B 183 8 HET ACT A1198 4 HET ACT A1199 4 HET CL A1200 1 HET CL A1201 1 HET CL A1202 1 HET HBA A1203 18 HET CL B1195 1 HET CL B1196 1 HET LDP B1197 11 HET HBA B1198 9 HETNAM MSE SELENOMETHIONINE HETNAM ACT ACETATE ION HETNAM CL CHLORIDE ION HETNAM HBA P-HYDROXYBENZALDEHYDE HETNAM LDP L-DOPAMINE HETSYN LDP DOPAMINE FORMUL 1 MSE 8(C5 H11 N O2 SE) FORMUL 3 ACT 2(C2 H3 O2 1-) FORMUL 5 CL 5(CL 1-) FORMUL 8 HBA 2(C7 H6 O2) FORMUL 11 LDP C8 H11 N O2 FORMUL 13 HOH *173(H2 O) HELIX 1 1 ILE A 36 SER A 40 5 5 HELIX 2 2 SER A 55 SER A 64 1 10 HELIX 3 3 TRP A 65 LYS A 70 5 6 HELIX 4 4 HIS A 71 LEU A 76 1 6 HELIX 5 5 TYR A 131 LEU A 134 5 4 HELIX 6 6 PHE A 167 GLU A 172 1 6 HELIX 7 7 THR A 177 GLU A 193 1 17 HELIX 8 8 SER B 55 SER B 64 1 10 HELIX 9 9 TRP B 65 LYS B 70 5 6 HELIX 10 10 HIS B 71 LEU B 76 1 6 HELIX 11 11 TYR B 131 LEU B 134 5 4 HELIX 12 12 PHE B 167 GLU B 172 1 6 HELIX 13 13 THR B 177 GLU B 193 1 17 SHEET 1 AA 8 LYS A 21 LEU A 24 0 SHEET 2 AA 8 LYS B 82 ILE B 86 -1 O LEU B 83 N LEU A 24 SHEET 3 AA 8 ILE B 94 THR B 98 -1 O ILE B 94 N ILE B 86 SHEET 4 AA 8 GLU B 107 ASP B 116 -1 O TYR B 108 N MSE B 97 SHEET 5 AA 8 LEU B 121 GLY B 129 -1 O LEU B 121 N ASP B 116 SHEET 6 AA 8 VAL B 136 PRO B 147 -1 O TYR B 139 N MSE B 126 SHEET 7 AA 8 CYS B 153 VAL B 163 -1 O VAL B 154 N VAL B 146 SHEET 8 AA 8 VAL B 42 VAL B 52 -1 O VAL B 42 N VAL B 163 SHEET 1 AB 7 VAL A 42 VAL A 52 0 SHEET 2 AB 7 SER A 152 VAL A 163 -1 O CYS A 153 N VAL A 52 SHEET 3 AB 7 VAL A 136 GLY A 149 -1 N THR A 137 O HIS A 162 SHEET 4 AB 7 LEU A 121 GLY A 129 -1 O LYS A 122 N ILE A 143 SHEET 5 AB 7 GLU A 107 ASP A 116 -1 O LYS A 109 N ILE A 127 SHEET 6 AB 7 ILE A 94 THR A 98 -1 O LEU A 95 N GLU A 110 SHEET 7 AB 7 LYS A 82 ILE A 86 -1 O LYS A 82 N THR A 98 LINK C ASP A 96 N MSE A 97 1555 1555 1.32 LINK C MSE A 97 N THR A 98 1555 1555 1.34 LINK C GLN A 125 N MSE A 126 1555 1555 1.33 LINK C MSE A 126 N ILE A 127 1555 1555 1.33 LINK C TYR A 139 N MSE A 140 1555 1555 1.33 LINK C MSE A 140 N ASP A 141 1555 1555 1.33 LINK C ALA A 182 N MSE A 183 1555 1555 1.33 LINK C MSE A 183 N ALA A 184 1555 1555 1.33 LINK C ASP B 96 N AMSE B 97 1555 1555 1.33 LINK C ASP B 96 N BMSE B 97 1555 1555 1.33 LINK C BMSE B 97 N THR B 98 1555 1555 1.33 LINK C AMSE B 97 N THR B 98 1555 1555 1.33 LINK C GLN B 125 N MSE B 126 1555 1555 1.33 LINK C MSE B 126 N ILE B 127 1555 1555 1.33 LINK C TYR B 139 N MSE B 140 1555 1555 1.33 LINK C MSE B 140 N ASP B 141 1555 1555 1.33 LINK C ALA B 182 N MSE B 183 1555 1555 1.33 LINK C MSE B 183 N ALA B 184 1555 1555 1.33 SITE 1 AC1 5 TRP A 65 GLY A 67 LYS A 70 HIS A 71 SITE 2 AC1 5 HIS B 71 SITE 1 AC2 5 VAL A 115 ASP A 116 ASN A 117 GLU A 118 SITE 2 AC2 5 HOH A2053 SITE 1 AC3 3 HIS A 106 GLU A 107 HOH A2062 SITE 1 AC4 1 ARG A 120 SITE 1 AC5 1 HIS A 144 SITE 1 AC6 4 HIS B 106 GLU B 107 GLY B 130 HOH B2050 SITE 1 AC7 1 HIS A 71 SITE 1 AC8 8 ILE A 36 LEU B 76 PHE B 80 MSE B 97 SITE 2 AC8 8 TYR B 108 GLU B 110 PRO B 179 HBA B1198 SITE 1 AC9 12 TYR A 63 LEU A 68 LEU A 95 MSE A 97 SITE 2 AC9 12 GLU A 110 PHE A 112 LYS A 122 VAL A 124 SITE 3 AC9 12 ASP A 141 ILE A 143 LEU A 180 MSE A 183 SITE 1 BC1 8 LYS B 122 VAL B 124 ASP B 141 ILE B 143 SITE 2 BC1 8 PRO B 179 LEU B 180 MSE B 183 LDP B1197 CRYST1 86.474 86.474 117.977 90.00 90.00 120.00 P 31 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011564 0.006677 0.000000 0.00000 SCALE2 0.000000 0.013353 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008476 0.00000